Comparison of the Effectiveness and Safety Between Tramadol 37.5 Mg/Acetaminophen 325mg And Gabapentin for The Treatment of Painful Diabetic Neuropathy: Multicenter, Randomized, Open Comparative Study
Completed Phase 4 NCT00634543
Study Description
The purpose of this study is to evaluate the effectiveness and safety of tramadol hydrochloride (HCl) 37.5 miligram (mg)/acetaminophen 325 mg compared to gabapentin in participants with diabetic neuropathic (nerve disorder caused by diabetes mellitus) pain.
Study Details
- Registry ID:
- NCT00634543
- Conditions:
- Diabetic Neuropathy
- Phase:
- Phase 4
- Target Enrollment:
- 162 participants
- Start Date:
- Age Range:
- 18–75 years
- Healthy Volunteers:
- No
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.